Catalyst Wire Dossier Catalyst Wire Dossier

Chloroprocaine HCl ophthalmic gel 3%

chloroprocaine hydrochloride
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Chloroprocaine HCl ophthalmic gel 3%, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections [Phase 4]

See pricing